Alexander Kiani

7.4k total citations
78 papers, 2.7k citations indexed

About

Alexander Kiani is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexander Kiani has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 27 papers in Hematology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander Kiani's work include Colorectal Cancer Treatments and Studies (32 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Alexander Kiani is often cited by papers focused on Colorectal Cancer Treatments and Studies (32 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Alexander Kiani collaborates with scholars based in Germany, Austria and France. Alexander Kiani's co-authors include Anjana Rao, Gerhard Ehninger, J. Aramburu, Martin Bornhäuser, Johannes Schetelig, João P. B. Viola, Uwe Platzbecker, Sebastian Stintzing, Ludwig Fischer von Weikersthal and Dominik Paul Modest and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Alexander Kiani

75 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Kiani Germany	25	1.1k	935	680	623	483	78	2.7k
Fernando Ravagnani Italy	26	1.2k 1.1×	928 1.0×	911 1.3×	904 1.5×	218 0.5×	64	3.1k
G. D. Demetri United States	25	1.0k 0.9×	626 0.7×	647 1.0×	890 1.4×	937 1.9×	75	3.1k
Thomas Klingebiel Germany	31	959 0.9×	541 0.6×	557 0.8×	328 0.5×	988 2.0×	90	3.2k
Naoki Hosen Japan	28	791 0.7×	659 0.7×	1.7k 2.5×	871 1.4×	387 0.8×	111	2.9k
Juan Luis Garcı́a Spain	29	984 0.9×	1.2k 1.3×	1.3k 1.9×	332 0.5×	277 0.6×	127	3.2k
Camille N. Abboud United States	27	783 0.7×	1.6k 1.7×	810 1.2×	558 0.9×	261 0.5×	109	2.7k
Hyeoung‐Joon Kim South Korea	29	909 0.8×	1.4k 1.5×	1.0k 1.5×	957 1.5×	139 0.3×	213	3.0k
Christoph Walz Germany	25	375 0.3×	792 0.8×	650 1.0×	466 0.7×	262 0.5×	70	2.1k
Piers Blombery Australia	26	675 0.6×	749 0.8×	826 1.2×	653 1.0×	181 0.4×	122	2.4k
Hani Hassoun United States	32	1.2k 1.1×	1.6k 1.8×	2.0k 2.9×	617 1.0×	439 0.9×	160	3.7k

Countries citing papers authored by Alexander Kiani

Since Specialization

Citations

This map shows the geographic impact of Alexander Kiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Kiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Kiani more than expected).

Fields of papers citing papers by Alexander Kiani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Kiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Kiani. The network helps show where Alexander Kiani may publish in the future.

Co-authorship network of co-authors of Alexander Kiani

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Kiani. A scholar is included among the top collaborators of Alexander Kiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Kiani. Alexander Kiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holch, Julian Walter, Sebastian Stintzing, Kathrin Heinrich, et al.. (2025). FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters. European Journal of Cancer. 220. 115388–115388.

Stahler, Arndt, Dominik Paul Modest, Sebastian Stintzing, et al.. (2024). Consensus molecular subtypes (CMS) as prognostic and predictive biomarkers of RAS wild-type (WT) metastatic colorectal cancer (mCRC): Pooled analysis of the randomized trials FIRE-1, FIRE-3, XELAVIRI, and PanaMa.. Journal of Clinical Oncology. 42(16_suppl). 3529–3529.

Holch, Julian Walter, Sebastian Stintzing, Kathrin Heinrich, et al.. (2024). Refining first-line treatment decision in RAS wildtype (RAS-WT) metastatic colorectal cancer (mCRC) by combining clinical biomarkers: Results of the randomized phase 3 trial FIRE-3 (AIO KRK0306).. Journal of Clinical Oncology. 42(3_suppl). 13–13. 1 indexed citations

Lorenzen, Sylvie, Thomas J. Ettrich, Federico Longo, et al.. (2023). S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial. ESMO Open. 8(3). 101572–101572. 1 indexed citations

Heinemann, Volker, Melvin D’Anastasi, Nina Hesse, et al.. (2022). Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306. European Radiology. 33(2). 1174–1184. 3 indexed citations

Dengler, Jolanta, et al.. (2022). Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices. Acta Haematologica. 145(6). 603–610. 3 indexed citations

Stahler, Arndt, Sebastian Stintzing, Dominik Paul Modest, et al.. (2020). Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials. Clinical Cancer Research. 26(24). 6559–6567. 20 indexed citations

Haag, Georg Martin, Sylvie Lorenzen, Thomas J. Ettrich, et al.. (2020). 1447P S-1 maintenance therapy in non-Asian patients with advanced, Her-2 negative esophagogastric adenocarcinoma – First results of the international MATEO trial initiated by the AIO. Annals of Oncology. 31. S910–S910. 2 indexed citations

Heinemann, Volker, Ludwig Fischer von Weikersthal, Thomas Decker, et al.. (2020). FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial. British Journal of Cancer. 124(3). 587–594. 94 indexed citations

10.

Holch, Julian Walter, Ingrid Ricard, Sebastian Stintzing, et al.. (2018). Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). European Journal of Cancer. 106. 115–125. 16 indexed citations

11.

Wein, Axel, Martin Emmert, Susanne Merkel, et al.. (2014). Palliative Treatment of Colorectal Cancer with Secondary Metastasis Resection in Germany - Impact of the Multidisciplinary Treatment Approach on Prognosis and Cost: The Northern Bavaria IVOPAK I Project. Oncology. 88(2). 103–121. 8 indexed citations

12.

Modest, Dominik Paul, Ludwig Fischer von Weikersthal, Sebastian Stintzing, et al.. (2013). FOLFIRI Plus Cetuximab Versus Folfiri Plus Bevacizumab as First-Line Treatment of KRAS-Wildtype Metastatic Colorectal Cancer: German AIO Study Krk-0306 (FIRE-3). Annals of Oncology. 24. iv22–iv22. 13 indexed citations

13.

Bauer, Wolfgang, Martina Rauner, Michael Haase, et al.. (2011). Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2. Haematologica. 96(11). 1580–1588. 18 indexed citations

14.

Platzbecker, Uwe, Malte von Bonin, Eray Goekkurt, et al.. (2009). Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial. Biology of Blood and Marrow Transplantation. 15(1). 101–108. 39 indexed citations

15.

Platzbecker, Uwe, Johannes Schetelig, Martin Wermke, et al.. (2009). ¹⁸⁸Re anti‐CD66 radioimmunotherapy combined with reduced‐intensity conditioning and in‐vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation. British Journal of Haematology. 148(6). 910–917. 13 indexed citations

16.

Freiberg‐Richter, Jens, Uwe Platzbecker, Alexander Kiani, et al.. (2008). Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Bone Marrow Transplantation. 42(2). 113–120. 31 indexed citations

17.

Minami, Takashi, et al.. (2008). Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytes. British Journal of Haematology. 144(3). 395–408. 10 indexed citations

18.

Pohlmann, Carsten, Johannes Schetelig, Ulrike Reuner, et al.. (2007). Cidofovir and Foscarnet for Treatment of Human Herpesvirus 6 Encephalitis in a Neutropenic Stem Cell Transplant Recipient. Clinical Infectious Diseases. 44(12). e118–e120. 39 indexed citations

19.

Kiani, Alexander, Anjana Rao, & J. Aramburu. (2000). Manipulating Immune Responses with Immunosuppressive Agents that Target NFAT. Immunity. 12(4). 359–372. 237 indexed citations

20.

Kiani, Alexander, João P. B. Viola, Andrew H. Lichtman, & Anjana Rao. (1997). Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1. Immunity. 7(6). 849–860. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact